Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer

Showing 15 posts of 1067 posts found.

Novartis offers $470m to boost personalised cancer treatment

January 24, 2011
Research and Development, Sales and Marketing Cancer, Genoptix, Novartis, cancer diagnostics, personalised medicine

Novartis has offered $470 million for a California-based laboratory whose diagnostic services it hopes will enhance personalised treatment. Genoptix specialises …

News
Roche building

Trial success for Roche’s personalised skin cancer drug

January 19, 2011
Research and Development BRAF V600, Cancer, RG7204, Roche, personalised medicine, skin cancer

A promising Roche drug has helped previously untreated patients with advanced skin cancer to live longer without their disease getting …

News

Anti-cancer stem cell drug starts clinical trials

January 14, 2011
Research and Development Cancer, GSK, GlaxoSmithKline, OMP-21M18, OMP-59R5, OncoMed, Stem cells, advanced solid tumour cancers

OncoMed and GSK’s novel anti cancer stem cell drug OMP-59R5 has begun clinical trials and could represent the future direction …

News
Pfizer's Lipitor tablet

Pfizer lung cancer drug gets ‘rolling’ fast-track status in US

January 13, 2011
Sales and Marketing Cancer, NSCLC, axitinib, bosutinib, crizotinib, non-small cell lung cancer

Pfizer has initiated a ‘rolling’ submission for its new oral ALK lung cancer drug crizotinib that could see it on …

News

New cancer strategy gets £750 million boost

January 13, 2011
Cancer, NHS, cancer funding, cancer strategy

The government has published a new ‘Strategy for Cancer’ that seeks to increase preventive measures and improve outcomes for oncology …

News
Amgen HQ

Amgen aims for oncology expansion and a wider denosumab license

January 12, 2011
Research and Development AMG- 479, AMG-386, Amgen, Cancer, Pancreatic cancer, denosumab, motasenib

Amgen is seeking to increase the use of its bone drug denosumab and further its reach into the oncology market, …

News

Dendreon eyes late 2011 European cancer vaccine filing

January 10, 2011
Sales and Marketing Cancer, Denreon, Provenge, cancer vaccine, sipuleucel, vaccines

Dendreon Group is to seek marketing authorisation in Europe for the world’s first immunotherapy cancer vaccine in late 2011 or …

News

Gilead set to acquire Arresto for $225 million

December 23, 2010
Research and Development AB0024, Arresto, Cancer, Gilead, advanced solid tumours, ambrisentan, fibrotic diseases, idiopathic pulmonary fibrosis

Gilead Sciences is set to acquire fellow California, US-based biotech Arresto for $225 million to bolster its early stage pipeline. …

News

Sanofi signs new oncology research deals

December 20, 2010
Research and Development Avila Therapeutics, Cancer, INDOX, India, Oxford University, Sanofi, Sanofi-Aventis, cancer research, covalent drugs

Sanofi-Aventis has signed two new cancer research deals, including one that will see it partner with Avila Therapeutics to discover …

News

Sanofi and Merck Serono to collaborate in oncology

December 17, 2010
Research and Development Cancer, MSC1936369B, Merck Serono, SAR245408, SAR245409, Sanofi, Sanofi-Aventis

Sanofi-Aventis and Merck Serono are to join forces to study three new cancer drug candidates. The collaboration will see the companies …

News

Tolerx to collaborate on first-in-class cancer antibody

December 2, 2010
Research and Development Cancer, T cell, Torelx, monoclonal antibody

US biopharma company Tolerx is to work with a non-profit cancer research fund to develop its first in class antibody …

News

Pharma unprepared for personalised oncology

November 29, 2010
Research and Development, Sales and Marketing Cancer, ESMO, ESMO Cancer Biology for Clinicians Symposium, oncology, personalised medicine

The new era of personalised cancer care requires different thinking from pharma companies, according to experts at the ESMO symposium. …

News

NICE recommends Herceptin for gastric cancer, blocks high dose Glivec

November 24, 2010
Sales and Marketing Cancer, GIST, Glivec, HER2, Herceptin, NICE, gastric cancer

NICE has recommended Roche’s cancer drug Herceptin for patients with HER2 metastatic gastric cancer. NICE was initially minded not to …

News

Denosumab approved for bone cancer use

November 19, 2010
Sales and Marketing Amgen, Cancer, Prolia, Xgeva, denosumab

Amgen’s denosumab has been approved in the US to prevent serious bone problems in patients with solid tumour cancers. Denosumab …

News

FDA approves Eisai breast cancer drug Halaven

November 16, 2010
Sales and Marketing Cancer, Eisai, FDA, Halaven, Xeloda, breast cancer, eribulin mesylate, metastatic breast cancer

The FDA has approved Eisai’s advanced breast cancer drug Halaven for use in heavily pre-treated breast cancer patients. Halaven (eribulin …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026